ConductScience.org, home

Paper40286161

Anticancer Activity and Safety Profile of Novel 1-(4-Fluorophenoxyacetyl)-4-substituted Thio/Semicarbazide Derivatives.

Kozyra P and 7 others. Molecules, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Anticancer Activity and Safety Profile of Novel 1-(4-Fluorophenoxyacetyl)-4-substituted Thio/Semicarbazide Derivatives. Papers, record 40286161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40286161

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anticancer Activity and Safety Profile of Novel 1-(4-Fluorophenoxyacetyl)-4-substituted Thio/Semicarbazide Derivatives.
PubMed
Journal
Molecules
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-04-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kozyra PPawełhttps://orcid.org/0000-0001-8071-8503
2Humeniuk EEwelinahttps://orcid.org/0000-0003-4356-0828
3Karczmarzyk ZZbigniew
4Borzęcki AAdrian
5Adamczuk GGrzegorzhttps://orcid.org/0000-0003-1677-7247
6Korga-Plewko AAgnieszkahttps://orcid.org/0000-0002-2027-9681
7Wysocki WWaldemarhttps://orcid.org/0000-0002-3205-114X
8Pitucha MMonikahttps://orcid.org/0000-0001-8792-1029

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SemicarbazidesMajor topic
Antineoplastic AgentsMajor topic
Humans
Cell Line, Tumor
Molecular Docking Simulation
Structure-Activity Relationship
Molecular Structure
Male
Cell Proliferation

Source PubMed

Download CSV of topics

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
226560244Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression.PLoS One2015https://conductscience.org/library/papers/26560244PubMed
311259830Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11259830PubMed
434301763ATR/ATM-Mediated Phosphorylation of BRCA1 T1394 Promotes Homologous Recombinational Repair and G2-M Checkpoint Maintenance.Cancer Res2021https://conductscience.org/library/papers/34301763PubMed
537175436FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022.Int J Mol Sci2023https://conductscience.org/library/papers/37175436PubMed
627218427A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules.ChemMedChem2016https://conductscience.org/library/papers/27218427PubMed
718197348Fluorine in medicinal chemistry.Chem Soc Rev2008https://conductscience.org/library/papers/18197348PubMed
826200936Applications of Fluorine in Medicinal Chemistry.J Med Chem2015https://conductscience.org/library/papers/26200936PubMed
936313628The role of BCL-2 family proteins in regulating apoptosis and cancer therapy.Front Oncol2022https://conductscience.org/library/papers/36313628PubMed
1025363687Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling.J Enzyme Inhib Med Chem2015https://conductscience.org/library/papers/25363687PubMed
1128067251Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse.Sci Rep2017https://conductscience.org/library/papers/28067251PubMed
1226501210Pharmacological effects of primaquine ureas and semicarbazides on the central nervous system in mice and antimalarial activity in vitro.Fundam Clin Pharmacol2016https://conductscience.org/library/papers/26501210PubMed
1324821317Design, synthesis and biological evaluation of novel thiosemicarbazide analogues as potent anticonvulsant agents.Bioorg Chem2014https://conductscience.org/library/papers/24821317PubMed
14320699942,4-Dichlorophenoxyacetic Thiosemicarbazides as a New Class of Compounds Against Stomach Cancer Potentially Intercalating with DNA.Biomolecules2020https://conductscience.org/library/papers/32069994PubMed
1522405290Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants.Eur J Med Chem2012https://conductscience.org/library/papers/22405290PubMed
1632596789Comparative biological study between quinazolinyl-triazinyl semicarbazide and thiosemicarbazide hybrid derivatives.Mol Divers2021https://conductscience.org/library/papers/32596789PubMed
1735204651Potential Anticancer Agents against Melanoma Cells Based on an As-Synthesized Thiosemicarbazide Derivative.Biomolecules2022https://conductscience.org/library/papers/35204651PubMed
1836012142Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022.Int J Mol Sci2022https://conductscience.org/library/papers/36012142PubMed
1929131470
Synthesis of some novel pyridine compounds containing bis-1,2,4-triazole/thiosemicarbazide moiety and investigation of their antioxidant properties, carbonic anhydrase, and acetylcholinesterase enzymes inhibition profiles.
J Biochem Mol Toxicol2018https://conductscience.org/library/papers/29131470PubMed
2012036371Molecular properties that influence the oral bioavailability of drug candidates.J Med Chem2002https://conductscience.org/library/papers/12036371PubMed
2132811412Thiosemicarbazides: Updates on Antivirals Strategy.Mini Rev Med Chem2020https://conductscience.org/library/papers/32811412PubMed

See all 66 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41901229Synthesis and Development of 3-((2,4-Difluorophenyl)Amino)Propanoic Acid Derivatives as an Antiproliferative Medicinal Chemistry Scaffold Targeting Growth Factor Receptors.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901229PubMed
41784864New molecules candidates with a semicarbazide scaffold - anticancer potential in view of research on their physicochemical properties, antioxidant activity, and preliminary biological activity.Pharmacol Rep2026https://conductscience.org/library/papers/41784864PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TOP2A7153PubTator's text mininghttps://conductscience.org/library/genes/7153

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40286161

GET https://conductscience.org/api/papers/v1/40286161/references?page=2